The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018

Paolo A Ascierto; Lisa H Butterfield; Sandra Demaria; Robert L Ferris; Gordon J Freeman; Roger S Lo; Alberto Mantovani; Paul Nathan; Omid Hamid; Katerina Politi; Igor Puzanov

doi:10.1186/s40425-019-0683-0

The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018

Paolo A Ascierto, Lisa H Butterfield, Sandra Demaria, Robert L Ferris, Gordon J Freeman, Roger S Lo, Alberto Mantovani, Paul Nathan, Omid Hamid, Katerina Politi, Igor Puzanov

Research output: Contribution to journal › Review article › peer-review

Abstract

As part of the 2018 Immunotherapy Bridge congress (November 28-29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-cancer immune response; the merits of combination versus sequential immunotherapy regimens in the treatment of cancer; the advantages and disadvantages of murine models of cancer versus humans in order to evaluate immunotherapy; and whether or not mechanisms of resistance to immunotherapy differ between different cancers. Discussion of these important topics are summarised in this report.

Original language	English
Pages (from-to)	221
Journal	Journal for ImmunoTherapy of Cancer
Volume	7
Issue number	1
DOIs	https://doi.org/10.1186/s40425-019-0683-0
Publication status	Published - Aug 15 2019

Access to Document

10.1186/s40425-019-0683-0

Cite this

@article{845844665e35454192c4a0575c5d8757,

title = "The great debate at {"}Immunotherapy Bridge 2018{"}, Naples, November 29th, 2018",

abstract = "As part of the 2018 Immunotherapy Bridge congress (November 28-29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-cancer immune response; the merits of combination versus sequential immunotherapy regimens in the treatment of cancer; the advantages and disadvantages of murine models of cancer versus humans in order to evaluate immunotherapy; and whether or not mechanisms of resistance to immunotherapy differ between different cancers. Discussion of these important topics are summarised in this report.",

author = "Ascierto, {Paolo A} and Butterfield, {Lisa H} and Sandra Demaria and Ferris, {Robert L} and Freeman, {Gordon J} and Lo, {Roger S} and Alberto Mantovani and Paul Nathan and Omid Hamid and Katerina Politi and Igor Puzanov",

year = "2019",

month = aug,

day = "15",

doi = "10.1186/s40425-019-0683-0",

language = "English",

volume = "7",

pages = "221",

journal = "Journal for ImmunoTherapy of Cancer",

issn = "2051-1426",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018

AU - Ascierto, Paolo A

AU - Butterfield, Lisa H

AU - Demaria, Sandra

AU - Ferris, Robert L

AU - Freeman, Gordon J

AU - Lo, Roger S

AU - Mantovani, Alberto

AU - Nathan, Paul

AU - Hamid, Omid

AU - Politi, Katerina

AU - Puzanov, Igor

PY - 2019/8/15

Y1 - 2019/8/15

N2 - As part of the 2018 Immunotherapy Bridge congress (November 28-29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-cancer immune response; the merits of combination versus sequential immunotherapy regimens in the treatment of cancer; the advantages and disadvantages of murine models of cancer versus humans in order to evaluate immunotherapy; and whether or not mechanisms of resistance to immunotherapy differ between different cancers. Discussion of these important topics are summarised in this report.

AB - As part of the 2018 Immunotherapy Bridge congress (November 28-29, Naples, Italy), the Great Debate session featured counterpoint views from leading experts on four topical clinical issues in immunotherapy today. These were: the relative importance of adaptive versus innate immunity in the anti-cancer immune response; the merits of combination versus sequential immunotherapy regimens in the treatment of cancer; the advantages and disadvantages of murine models of cancer versus humans in order to evaluate immunotherapy; and whether or not mechanisms of resistance to immunotherapy differ between different cancers. Discussion of these important topics are summarised in this report.

U2 - 10.1186/s40425-019-0683-0

DO - 10.1186/s40425-019-0683-0

M3 - Review article

C2 - 31416487

SN - 2051-1426

VL - 7

SP - 221

JO - Journal for ImmunoTherapy of Cancer

JF - Journal for ImmunoTherapy of Cancer

IS - 1

ER -

The great debate at "Immunotherapy Bridge 2018", Naples, November 29th, 2018

Abstract

Access to Document

Fingerprint

Cite this